Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Full Schedule

Full Schedule

  • Wednesday, April 20, 2022
  • 7:00 AM – 8:00 AM ET
    Open 12-Step Meeting
  • 8:00 AM – 8:45 AM ET
    Vision Sessions

    Vision Session

  • 8:45 AM – 9:00 AM ET
    Break
  • 9:00 AM – 11:00 AM ET
    Plenary Session
  • 11:00 AM – 11:15 AM ET
    Break
  • 11:00 AM – 2:00 PM ET
    Lunch in Exhibit Hall
  • 11:15 AM – 12:30 PM ET
    TECH-20-1115 - Assessing Consumer-Facing Mobile Apps for Recovery Management for People With Opioid Use Disorder
  • 11:15 AM – 12:30 PM ET
    CL-20-1115 - Addiction Workforce Gaps: Using Project ECHO to Engage Rural Providers and Medical Students
  • 11:15 AM – 12:30 PM ET
    ADV-20-1115 - Reframing the Drug Epidemic as Commercialized Recreational Pharmacology
  • 11:15 AM – 12:30 PM ET
    ILL-20-1115 - Counterfeit Pills: What Every American Should Know
  • 11:15 AM – 12:30 PM ET
    PO-20-1115 - Post-Overdose Outreach Program in Massachusetts
  • 12:30 PM – 12:45 PM ET
    Break
  • 12:45 PM – 2:00 PM ET
    PO-20-1245-A412 - Harm Reduction Principles and Their Effective Application
  • 12:45 PM – 2:00 PM ET
    TREAT-20-1245 - Implementation and Evaluation of PEERhelp Rural Communities Opioid Response Program
  • 12:45 PM – 2:00 PM ET
    TECH-20-1245 - Identifying High-Risk Patients With PDMPs
  • 12:45 PM – 2:00 PM ET
    TREND-20-1245 - Expanding Rural Access to Medication Assisted Treatment During COVID-19 and Other Adverse Conditions
  • 12:45 PM – 2:00 PM ET
    PS-20-1245 - New Jersey’s Multi-Disciplinary Framework: Developing Forensic Intelligence and Creating a New Culture Linking Individuals With Substance Use Disorder to Appropriate Levels of Care
  • 2:00 PM – 2:15 PM ET
    Break
  • 2:15 PM – 3:30 PM ET
    PO-20-215-A411 - Statewide Quick Response Teams: Lessons From Ohio and West Virginia
  • 2:15 PM – 3:30 PM ET
    PO-20-215-A412 - Naloxone Initiatives and Syringe Service Programs in the Veterans Health Administration: Critical Lessons During the Fourth Wave
  • 2:15 PM – 3:30 PM ET
    CL-20-215 - Increasing Buprenorphine Access in Rural North Carolina via Innovative Pharmacy-Focused Solutions
  • 2:15 PM – 3:30 PM ET
    PS-20-215 - Role of Medicaid and Department of Corrections: Pre-Release and Substance Use Disorder Care
  • 2:15 PM – 3:30 PM ET
    ADV-20-215 - Children Affected by Substance Abuse: A Multidisciplinary Approach to Serving the Epidemic’s Most Vulnerable Victims
  • 2:15 PM – 3:30 PM ET
    TREAT-20-215 - Bringing Alternative Services to Rural Communities
  • 2:15 PM – 3:30 PM ET
    TECH-20-215 - Out of the Box: New Methods to Identify Emerging Drug Threats
  • 2:15 PM – 3:30 PM ET
    TREND-20-215 - Engaging Employers to Support Employees in Treatment and Hire People in Recovery
  • 2:15 PM – 3:30 PM ET
    ILL-20-215 - CReDO: Community Response to Drug Overdoses
  • 3:30 PM – 4:30 PM ET
    Break in Exhibit Hall
  • 4:30 PM – 5:45 PM ET
    PO-20-430-A411 - Public Health and Public Safety Partnerships for Overdose Prevention and Response
  • 4:30 PM – 5:45 PM ET
    PO-20-430-A412 - Medical Examiners: Supporting Overdose Prevention and Training for Overdose Investigations and Mortality Data
  • 4:30 PM – 5:45 PM ET
    CL-20-430 - Naloxone for Risk Management in Primary Care, Pharmacy, Families, and Beyond
  • 4:30 PM – 5:45 PM ET
    PS-20-430 - State Efforts to Improve Outcomes for Justice-Involved Individuals With Opioid Use Disorder in Correctional Facilities and on Community Supervision
  • 4:30 PM – 5:45 PM ET
    ADV-20-430 - Project Hope: Supporting the Path to Recovery Through Partnerships
  • 4:30 PM – 5:45 PM ET
    TREAT-20-430 - Tennessee Recovery Navigators: Connecting Patients to Treatment From Hospital Emergency Departments
  • 4:30 PM – 5:45 PM ET
    TECH-20-430 - Using Geospatial Data to Identify Gaps in Substance Use Disorder Treatment
  • 4:30 PM – 5:45 PM ET
    TREND-20-430 - The New Age of Telehealth: What Is Working
  • 4:30 PM – 5:45 PM ET
    ILL-20-430 - Insights From State Data Into Deaths Related to Fentanyl, Fentanyl Analogs, Psychostimulants, and Novel Psychoactive Substances
  • 5:45 PM – 6:00 PM ET
    Break
  • 6:00 PM – 7:00 PM ET
    Plenary Session